Company Description
WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally.
It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes, as well as offers guidance and medication access for women reaching perimenopause and menopause.
The company also provides Core, a digital subscription product for weight loss and weight management; Core+ tier, a subscription for unlimited access to workshops; and Med+ subscription tier provides unlimited access to a clinician who can prescribe medications when clinically appropriate, including oral and injectable GLP 1s and hormone replacement therapy.
In addition, it licenses its trademarks and other intellectual property in food, beverages, and other weight management-relevant consumer products and services, as well as provides publishing services.
The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019.
WW International, Inc. was founded in 1963 and is headquartered in New York, New York.
| Country | United States |
| Founded | 1963 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 3,500 |
| CEO | Jonathan Volkmann |
Contact Details
Address: 18 West 18th Street, 7th Floor New York, New York 10011 United States | |
| Phone | 212 589 2700 |
| Website | corporate.ww.com |
Stock Details
| Ticker Symbol | WW |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 105319 |
| CUSIP Number | 98262P101 |
| ISIN Number | US98262P2002 |
| Employer ID | 11-6040273 |
| SIC Code | 7200 |
Key Executives
| Name | Position |
|---|---|
| Julie J. Rice | Chief Experience Officer |
| Felicia DellaFortuna | Chief Financial Officer and Member of Interim Office of the Chief Executive |
| Jonathan Volkmann | Chief Operating Officer and Interim Principal Executive Officer |
| Nicole Haag | Corporate Controller and Principal Accounting Officer |
| Helene Causse | Chief Technology Officer |
| David Helderman | Director of Investor Relations |
| Debra Cotter | Chief Legal Officer and Secretary |
| Nina George | Chief Marketing and Consumer Strategy Officer |
| Tony Yen | Head of Taiwan |
| Scott Honken PharmD | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 30, 2026 | ARS | Filing |
| Apr 30, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 27, 2026 | 8-K | Current Report |
| Apr 20, 2026 | 8-K | Current Report |
| Apr 17, 2026 | 8-K | Current Report |
| Apr 9, 2026 | 8-K/A | [Amend] Current report |
| Apr 7, 2026 | 8-K | Current Report |
| Apr 3, 2026 | 8-K | Current Report |
| Mar 26, 2026 | SCHEDULE 13G/A | Filing |
| Mar 19, 2026 | SCHEDULE 13G | Filing |